Work

A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia

Year: 2008

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-008-9129-0

Authors: Wendy Stock, Samir D. Undevia, Carol Bivins, Farhad Ravandi, Olatoyosi Odenike, Stefan Faderl, Elizabeth Rich, Gautam Borthakur, Lucy Godley, Srdan Verstovsek, Andrew Artz, William Wierda, Richard A. Larson, Yanming Zhang, Jorge Cortes, Mark J. Ratain, Francis J. Giles

Institutions: University of Chicago, The University of Texas MD Anderson Cancer Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1945244547, Phase I Studies of Targeted Anti-Cancer Therapies, Phase I Clinical Trials of Anti-Cancer Agents, Cancer Center Support Grant, Cancer Center Support Grant

OpenAlex ID: W2106128593

FWCI: 0.642

Cites: 10

Cited by: 11

Related to: 10